Hologic Locks Down 4th M&A Target This Year
Tada Images -stock.adobe.com The Waltham, MA-based company is set to acquire Mobidiag Oy, a molecular diagnostics firm, for about $795 million. It doesn’t look like Hologic will be slowing down with M&A this year. The Waltham, MA-based company has announced its fourth deal – the proposed acquisition of Mobidiag Oy, a molecular diagnostics firm, for about $795 million. The acquisition is expected to close early in 4Q21. Mobidiag develops PCR (polymerase chain reaction)-based tests for acute care conditions such as gastrointestinal and respiratory infections, antim...
Source: mddionline.com